Paclitaxel (Taxol) CAS 33069-62-4 Assay (HPLC) 97.0 ~ 102.0%

Nkọwa dị mkpirikpi:

Aha Chemical: Paclitaxel

Ihe atụ: Taxol

Nọmba: 33069-62-4

Nyocha (HPLC): 97.0 ~ 102.0%

Ọdịdị: White Crystalline ntụ ntụ, enweghị isi

Kpọtụrụ: Dr. Alvin Huang

Mobile/Wechat/WhatsApp: +86-15026746401

E-Mail: alvin@ruifuchem.com


Nkọwa ngwaahịa

Ngwaahịa ndị emetụtara

Mkpado ngwaahịa

33069-62-4 - Nkọwa:

Shanghai Ruifu Chemical Co., Ltd bụ onye na-emepụta Paclitaxel (Taxol) (CAS: 33069-62-4) nwere àgwà dị elu.Ruifu Chemical nwere ike ịnye nnyefe zuru ụwa ọnụ, ọnụahịa asọmpi, ọrụ magburu onwe ya, obere na nnukwu ọnụọgụ dị.Ịzụta Paclitaxel (Taxol),Please contact: alvin@ruifuchem.com

33069-62-4 - Njirimara Chemical:

Aha Chemical Paclitaxel
Ụdị okwu Taxol;Abraxane;Genaxol;Genetaxyl;OncoGel;Pacliex;(-) Paclitaxel
Ọnọdụ Ahịa Na ngwaahịa, Mmepụta Azụmahịa
Nọmba CAS 33069-62-4
Usoro ihe omimi C47H51NO14
Ibu molekụla 853.92 g/mol
Ebe Na-agbaze 211 ℃ (Dec.)
Njupụta 0,200
Mmiri Solubility Na-adịghị edozi n'ime mmiri
Solubility Na-agbaze ngwa ngwa na Chloroform, Acetone na ihe mgbaze organic ndị ọzọ.
Nkwụsi ike Kwụsie ike.Ekwekọrịtaghị na Agents Oxidizing siri ike.Enwere ike ịgbanwu ọkụ.
COA & MSDS Dị
Ihe atụ Dị
Mmalite Shanghai, China
Ụdị Ruifu Chemical

33069-62-4 - Nkọwapụta:

Ihe Nkọwapụta Nsonaazụ
Ọdịdị Ntụ ntụ kristal ọcha, enweghị isi Na-akwado
njirimara (A) IR: Concordant na RS Na-akwado
njirimara (B) HPLC: RT Concordant nwere RS Na-akwado
Ntụgharị akọwapụtara -49.0° ruo -55.0° -52.3°
Mmiri nke Karl Fischer ≤4.00% 0.91%
Ihe fọdụrụ na mgbanye ≤0.20% 0.02%
Ọla dị arọ (Pb) ≤20ppm <20ppm
Ngwakọta ndị emetụtara    
Mkpokọta ≤2.00% 0.11%
10-Deacetylbaccatin III ≤0.10% Achọpụtaghị
Baccatin III ≤0.20% Achọpụtaghị
Onye na-ese foto ≤0.10% Achọpụtaghị
10-Deacetylpaclitaxel ≤0.50% 0.04%
2-Debenzoylpaclitaxel-2-Pentenoate ≤0.70% Achọpụtaghị
7-Epipaclitaxel ≤0.40% 0.014%
10,13-Bissidechainpaclitaxel ≤0.50% 0.022%
7-Acetylpaclitaxel ≤0.60% Achọpụtaghị
13-Tes-baccatin III ≤0.10% 0.004%
7-Tes-Paclitaxel ≤0.30% Achọpụtaghị
Ihe adịghị ọcha ndị ọzọ ≤0.10% Na-akwado
0rganic adịghị eme ihe na-adịghị mma   Na-akwado
Hexan ≤290ppm 31ppm
Aceton ≤5000ppm 1210 ppm
Nyocha (HPLC) 97.0 ~ 102.0% (gbakọọ na anhydrous, ihe mgbaze-free ndabere) 99.88%
Nnwale oke microbial
Ngụkọta ọnụ ọgụgụ microbial nke ikuku ikuku ≤100 cfu/g <100 cfu/g
Staphylococcus Aureus Enweghị Enweghị
Salmonella Enweghị Enweghị
Escherichia Coli Enweghị Enweghị
Endotoxins nke nje bacteria ≤0.4EU/mg <0.4EU/mg
Mmechi A nwalela ngwaahịa a wee kwado USP43 Paclitaxel

Ngwugwu/Nkwakọba/Mbupu:

ngwugwu:Fluorinated Bottle, Aluminom foil bag, 25kg / Cardboard Drum, ma ọ bụ dị ka ndị ahịa chọrọ.
Ọnọdụ Nchekwa:Debe akpa ahụ nke ọma ma chekwaa n'ebe dị jụụ, kpọrọ nkụ (2 ~ 8 ℃) yana ụlọ nkwakọba ihe nke ọma na-esi na ihe ndị na-adabaghị adaba.Chebe site na ìhè na mmiri mmiri.
Mbupu:Jiri ikuku na-ebuga ụwa niile site na FedEx / DHL Express.Nye nnyefe ngwa ngwa na ntụkwasị obi.

33069-62-4 - ọkọlọtọ USP:

Paclitaxel
C47H51NO14 853.91
Benzenepropanoic acid, (benzoylamino) --hydroxy-, 6,12b-bis (acetyloxy) -12- (benzoyloxy) -2a,3,4,4a,5,6,9,10,11,12,12a,12b -dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4] benz [1,2-b] oxet-9-yl ester, [2aR-[2a,4,4a,6,9(R*,S*),11,12,12a,12b]]-.
(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-1,2a,3,4,4a,6,9,10,11,12,12a,12b-Dodecahydro-4,6, 9,11,12,12b-hexahydroxy-4a,8,13,13-tetramethyl-7,11-methano-5H-cyclodeca[3,4]-benz[1,2-b]oxet-5-otu 6, 12b-diacetate, 12-benzoate, 9-ester nwere (2R,3S) -N-benzoyl-3-phenylisoserine [33069-62-4].
Paclitaxel nwere ihe na-erughị 97.0 pasent na ọ bụghị karịa 102.0 pasent nke C47H51NO14, gbakọọ na anhydrous, ihe mgbaze na-enweghị ndabere.
[Akpachara anya-Paclitaxel bụ cytotoxic.Ekwesịrị ịkpachapụ anya nke ukwuu iji gbochie iku ume nke Paclitaxel na ikpughe akpụkpọ ahụ na ya.]
Nkwakọ ngwaahịa na nchekwa - Chekwaa n'ime akpa siri ike, nke na-enweghị ọkụ, ma chekwaa na ụlọ okpomọkụ a na-achịkwa.
Ịkpọ aha-Ngosipụta aha na-egosi ụdị usoro eji emepụta ihe na ule njikọ njikọ nke ihe ahụ na-akwado.
Ụkpụrụ ntụaka USP <11>-
USP Endotoxin RS
USP Paclitaxel RS Pịa ka ilele Ọdịdị
Ngwakọta jikọrọ USP Paclitaxel A RS
Cephalomannine.
Ihe jikọrọ USP Paclitaxel B RS
10-Deacetyl-7-Epipaclitaxel.
Ngwakọta USP Paclitaxel adịghị ọcha RS
Ngwakọta nke Paclitaxel na ogige ndị metụtara ya: propyl analọg, cephalomannine, sec-butyl analọgụ, n-butyl analọg, analọg benzyl, baccatin VI, pentyl analọg, na 7-epipaclitaxel.
njirimara-
A: Infrared absorption <197K>.
B: Oge njide nke nnukwu ọnụ ọgụgụ dị elu na chromatogram nke nkwadebe Assay kwekọrọ na nke ahụ na chromatogram nke nkwadebe Standard, dị ka enwetara na Assay.
Specific ntụgharị 781S: n'etiti 49.0 na 55.0 na 20, gbakọọ na anhydrous, ihe mgbaze-free ndabere.
Ngwọta ule: 10 mg kwa ml, na methanol.
Nnwale ngụkọ microbial <61> na Nnwale maka microorganisms akọwapụtara <62>-Ngụkọta ọnụ ọgụgụ microbial aerobic anaghị agafe 100 cfu kwa g.Ọ na-emezu ihe achọrọ maka ule maka enweghị Staphylococcus aureus, Pseudomonas aeruginosa, ụdị Salmonella, na Escherichia coli.
Endotoxins nke nje bacteria 85-O nwere ọ bụghị ihe karịrị 0.4 USP Endotoxin Unit kwa mg nke paclitaxel.
Mmiri, Usoro Ic <921>: ọ bụghị karịa 4.0%.
Ihe fọdụrụ na mgbanye <281>: ọ bụghị karịa 0.2%.
Ọla dị arọ, Usoro II <231>: 0.002%.
Ngwakọta ndị emetụtara-
nwale 1 (maka ihe akpọrọ dị ka ndị dịpụrụ adịpụ site na isi mmalite) -Ọ bụrụ na ihe ahụ kwekọrọ n'ule a, akara ngosi ahụ na-egosi na ọ na-ezute Ogwe Njikọ USP 1.
Diluent- Kwadebe dị ka a gwara ya na Assay.
Ngwọta A- Kwadebe acetonitrile akọrọ na degassed.
Ngwọta B- Kwadebe mmiri akọrọ na nke ikuku.
Usoro mkpanaaka-Jiri ngwakọta agbanwe agbanwe nke Ngwọta A na Ngwọta B dịka akwadoro maka sistemụ Chromatographic.Mee mgbanwe ọ bụrụ na ọ dị mkpa (lee Dabara Sistemu n'okpuru Chromatography 621).
Ngwọta dabara adaba sistemu-Gbasa n'ụzọ ziri ezi nke USP Paclitaxel Related Compound A RS na USP Paclitaxel Related Compound B RS na methanol iji nweta ihe ngwọta n'inwe ihe dị ka 10 µg nke ọ bụla kwa ml.Nyefee 5.0 ml nke ngwọta a na flask volumetric 50-mL, gbanye ya na Diluent na olu, na mix.
Ọkọlọtọ ngwọta-agbari, site n'enyemaka nke sonication, ihe ziri ezi tụrụ ibu nke USP Paclitaxel RS na diluent, na itughari quantitatively, na stepwise ma ọ bụrụ na ọ dị mkpa, na diluent nweta ngwọta na-enwe a maara ịta nke banyere 5 µg kwa ml.
Ngwọta nwale-Jiri nkwadebe Assay.
Usoro Chromatographic (lee Chromatography <621>) -Kromatograph mmiri mmiri nwere ihe nchọta 227-nm yana kọlụm 4.6-mm × 25-cm nke nwere ngwugwu 5-µm L43.Ọnụego ya bụ ihe dịka 2.6 ml kwa nkeji.A na-edobe okpomoku kọlụm na 30. A na-ahazi chromatograph dị ka ndị a.
Oge (nkeji) Ngwọta A (%) Ngwọta B (%) Elution
0–35 35 65 isocratic
35–60 35®80 65®20 gradient linear
60–70 80®35 20®65 gradient ahịrị
70-80 35 65 isocraticChromatograph the System suitability solution, ma dekọọ nzaghachi kacha elu dị ka akwadoro maka Usoro: oge ​​njide dị n'ihe gbasara 0.78 maka paclitaxel metụtara compound A na 0.86 maka paclitaxel metụtara compound B (n'ihe metụtara oge njide maka paclitaxel nwetara site na ya. ngwọta ule);na mkpebi, R, n'etiti paclitaxel metụtara compound A na paclitaxel metụtara compound B erughị 1.0.Chromatograph the Standard solution, wee dekọọ nzaghachi kacha elu dị ka akwadoro maka Usoro: ụkpụrụ agbakwunyere maka injections oyiri abụghị ihe karịrị 2.0%.
Usoro-Tinye otu olu (ihe dị ka 15 µL) nke ngwọta Nnwale n'ime chromatograph, dekọọ chromatogram, ma tụọ mpaghara maka ọnụ ọgụgụ kacha elu.Gbakọọ pasent nke adịghị ọcha ọ bụla na mpaghara Paclitaxel nke usoro a were were:
100 (Fri / rU)
nke F bụ ihe nzaghachi nzaghachi maka ọnụ ọgụgụ adịghị ọcha ọ bụla (lee Tebụl 1 maka ụkpụrụ);ri bụ ebe kacha elu maka adịghị ọcha onye ọ bụla;na rU bụ mpaghara kacha elu maka paclitaxel.
Tebụl 1
Oge Njide Ọdịnala Ihe Nzaghachi Ọdịnaya (F) Oke Aha (%)
0.24 1.29 Baccatin III 0.2
0.53 1.00 10-Deacetylpaclitaxel 0.5
0.57 1.00 7-Xylosylpaclitaxel 0.2
0.78 1.26 Cephalomannine (ihe metụtara Paclitaxel A) a11
0.78 1.26 2'',3''-Dihydrocephalomannine a21
0.86 1.00 10-Deacetyl-7-epipaclitaxel (ihe metụtara Paclitaxel B) 0,5
1.10 1.00 Benzyl analọgụ3 b12
1.10 1.00 3'',4''-Dehydropaclitaxel C b22
1.40 1.00 7-Epicephalomanine 0.3
1.85 1.00 7-Epipaclitaxel 0.5
1 Mkpebi nwere ike ezughị oke maka ọnụ ọgụgụ ndị a, dabere na ọnụọgụ ndị dị ugbu a;Nchikota nke a1 na a2 abụghị ihe karịrị 0.5%.
2 Mkpebi nwere ike ezughị oke maka ọnụ ọgụgụ ndị a, dabere na ọnụọgụ ndị dị ugbu a;Nchikota nke b1 na b2 abụghị ihe karịrị 0.5%.
3 A na-ekenye aha kemịkalụ na-esote ya na ogige metụtara ya, analọg benzyl:Baccatin III 13-ester na (2R,3S) -2-hydroxy-3-phenyl-3- (2-phenylacetylamino)propanoic acid.
Na mgbakwunye na ịgafeghị oke maka adịghị ọcha metụtara paclitaxel na Tebụl 1, a na-ahụ ihe karịrị 0.1% nke adịghị ọcha ọ bụla ọzọ;na ọ bụghị ihe karịrị 2.0% nke mkpokọta adịghị achọta.
nwale 2 (maka ihe akpọrọ dị ka usoro semisynthetic mepụtara) - Ọ bụrụ na ihe ahụ kwekọrọ n'ule a, akara ngosi ahụ na-egosi na ọ na-ezute ogige USP metụtara Test 2.
Diluent-Jiri acetonitrile.
Ngwọta A-Jiri ngwakọta nke mmiri na acetonitrile (3:2) gbakọrọ na nke ikuku.
Ngwọta B-Jiri acetonitrile akọrọ na degassed.
Usoro mkpanaaka-Jiri ngwakọta agbanwe agbanwe nke Ngwọta A na Ngwọta B dịka akwadoro maka sistemụ Chromatographic.Mee mgbanwe ọ bụrụ na ọ dị mkpa (lee Dabara Sistemu n'okpuru Chromatography 621).
Ngwọta dabara adaba nke sistemu-Gbasa n'ụzọ ziri ezi nke USP Paclitaxel RS na USP Paclitaxel Related Compound B RS na diluent, na-ama jijiji ma na-eme mkpọtụ ma ọ bụrụ na ọ dị mkpa, iji nweta ihe ngwọta ebe amaara ọkwa nke ihe dịka 0.96 mg na 0.008 mg kwa ml, n'otu n'otu.
Nnwale ule - Nyefee ihe dị ka 10 mg nke Paclitaxel, tụọ ya nke ọma, na flask volumetric 10-mL, gbazee ma gbanye ya na Diluent na olu, na-ama jijiji ma na-emegharị ma ọ bụrụ na ọ dị mkpa, na mix.
Usoro Chromatographic (lee Chromatography 621) - chromatograph mmiri mmiri nwere ihe nchọta 227-nm yana kọlụm 4.6mm × 15-cm nke nwere ngwugwu 3-µm L1.Onu ogugu a bu ihe dika 1.2 ml kwa nkeji.A na-edobe okpomọkụ kọlụm na 35. A na-ahazi chromatograph dị ka ndị a.
Oge (nkeji) Ngwọta A (%) Ngwọta B (%) Elution
0-20 100 0 isocratic
20-60 100®10 0®90 gradient ahịrị
60-62 10®100 90®0 gradient ahịrị
62-70 100 0 isocraticChromatograph the System suitability solution, ma dekọọ nzaghachi kacha elu dị ka akwadoro maka Usoro: oge ​​njide nke ikwu bụ ihe dịka 0.94 maka paclitaxel metụtara compound B na 1.0 maka paclitaxel;mkpebi, R, n'etiti paclitaxel metụtara compound B na paclitaxel abụghị ihe na-erughị 1.2;na ndị ikwu ọkọlọtọ ndiiche maka oyiri injections abụghị ihe karịrị 2.0%.
Usoro-iche iche, gbanye nha nha nha nha (ihe dịka 15 µL) nke ihe ngwọta na ngwọta ule n'ime chromatograph, dekọọ chromatograms, ma tụọ mpaghara maka ọnụ ọnụ ọnụ.Na-eleghara ọnụ ọgụgụ kasị elu ọ bụla n'ihi diluent.Gbakọọ pasent nke adịghị ọcha ọ bụla na mpaghara Paclitaxel nke usoro a were were:
100 (Fri / s)
nke F bụ ihe nzaghachi nzaghachi maka adịghị ọcha ọ bụla (lee Tebụl 2 maka ụkpụrụ);ri bụ ebe kachasị elu maka adịghị ọcha ọ bụla enwetara site na ngwọta ule;na rs bụ nchikota nke mpaghara nke ọnụ ọgụgụ kasị elu niile enwetara site na ngwọta ule.
Tebụl 2
Oge Njide Ọdịnala Ihe Nzaghachi Ọdịnaya (F) Oke Aha (%)
0.11 1.24 10-Deacetylbaccatin III 0.1
0.20 1.29 Baccatin III 0.2
0.42 1.39 Photodegradant2 0.1
0.47 1.00 10-Deacetylpaclitaxel 0.5
0.80 1.00 2-Debenzoylpaclitaxel-2-pentenoate 0.7
0.921 1.00 Oxetane meghere, acetyl na benzoyl kwagara2 x1
0.921 1.00 10-Acetoacetylpaclitaxel x2
0.941 1.00 10-Deacetyl-7-epipaclitaxel (ihe metụtara Paclitaxel B) x3
1.37 1.00 7-Epipaclitaxel 0.4
1.45 1.00 10,13-Bissidechainpaclitaxel2 0,5
1.54 1.00 7-Acetylpaclitaxel 0.6
1.80 1.75 13-Tes-baccatin III 0.1
2.14 1.00 7-Tes-paclitaxel 0.3
1 Mkpebi nwere ike ezughị oke maka ọnụ ọgụgụ ndị a, dabere na ọnụọgụ ndị dị ugbu a;Nchikota nke x1, x2, na x3 abụghị ihe karịrị 0.4%.
2 A na-ekenye aha kemịkal ndị a na ogige ndị metụtara Photodegradant;Oxetane mgbanaka meghere, acetyl na benzoyl kwagara;na 10,13-Bissidechainpaclitaxel:
Onye na-ese foto
(1R,2R,4S,5S,7R,10S,11R,12S,13S,15S,16S)-2,10-diacetyloxy-5,13-dihydroxy-4,16,17,17-tetramethyl-8-oxa- 3-oxo-12-phenylcarbonyloxypentacyclo [11.3.1.01,11.04,11.07,10] heptadec-15-yl
(2R, 3S) -2-hydroxy-3-phenyl-3- (phenylcarbonylamino) propanoate.
Oxetane mgbanaka meghere, acetyl na benzoyl kwagara
(1S,2S,3R,4S,5S,7S,8S,10R,13S)-5,10-diacetyloxy-1,2,4,7-tetrahydroxy-8,12,15,15-tetramethyl-9-oxo- 4- (phenylcarbonyloxymethyl) tricyclo[9.3.1.03,8] pentadec-11-en-13-yl
(2R, 3S) -2-hydroxy-3-phenyl-3- (phenylcarbonylamino) propanoate.
10,13-Bissidechainpaclitaxel
Baccatin III 13-ester na (2R,3S) -2-hydroxy-3-phenyl-3- (phenylcarbonylamino) propanoic acid, 10-ester na (2S,3S) -2-hydroxy-3-phenyl-3- (phenylcarbonylamino). ) propanoic acid
Na mgbakwunye na ịgafeghị oke maka adịghị ọcha metụtara paclitaxel na tebụl 2, ọ bụghị ihe karịrị 0.1% nke adịghị ọcha ọ bụla ọzọ ka a hụrụ;na ọ bụghị ihe karịrị 2.0% nke mkpokọta adịghị achọta.
nwale 3 (maka ihe akpọrọ dị ka usoro mkpụrụ ndụ ihe ọkụkụ na-emepụta) - Ọ bụrụ na ihe ahụ kwekọrọ n'ule a, akara ngosi na-egosi na ọ na-ezute ogige USP metụtara Test 3.
Ngwọta A- Kwadebe ngwakọta nke mmiri na acetonitrile (3:2).
Ngwọta B- Kwadebe acetonitrile akọrọ na degassed.
Usoro mkpanaaka-Jiri ngwakọta agbanwe agbanwe nke Ngwọta A na Ngwọta B dịka akwadoro maka sistemụ Chromatographic.Mee mgbanwe ọ bụrụ na ọ dị mkpa (lee Dabara Sistemu n'okpuru Chromatography 621).
Ngwọta dabara adaba nke sistemu - Gbanyụọ USP Paclitaxel adịghị ọcha ngwakọta RS na acetonitrile, sonicating ma ọ bụrụ na ọ dị mkpa, iji nweta ihe ngwọta na-enwe a maara ịta nke banyere 1 mg kwa ml.
Ọkọlọtọ ngwọta-Kwụsị n'ụzọ ziri ezi nke USP Paclitaxel RS na acetonitrile, sonicating ma ọ bụrụ na ọ dị mkpa, iji nweta ngwọta na-enwe a maara ịta nke banyere 1 mg kwa ml.
Ngwọta nnwale - Nyefee ihe dịka 10 mg nke Paclitaxel, tụọ ya nke ọma, gaa na flask volumetric 10-mL.Gbanyụọ ma gbanye ya na acetonitrile ka ọ bụrụ olu, na-emegharị ma ọ bụrụ na ọ dị mkpa, ma gwakọta ya.
Usoro Chromatographic (lee Chromatography 621) - chromatograph mmiri mmiri nwere ihe nchọta 227-nm yana kọlụm 4.6mm × 15-cm nke nwere ngwugwu 3-µm L1.Onu ogugu a bu ihe dika 1.2 ml kwa nkeji.A na-ahazi chromatograph dị ka ndị a.
Oge (nkeji) Ngwọta A (%) Ngwọta B (%) Elution
0-28 100 0 isocratic
28-33 100®98 0®2 gradient ahịrị
33–58 98®10 2®90 gradient ahịrị
58-60 10 90 isocratic
60-63 10®100 90®0 gradient ahịrị
63-70 100 0 isocraticChromatograph nke dabara adaba sistemu, wee dekọọ nzaghachi kacha elu dị ka akwadoro maka Usoro: mkpebi, R, n'etiti paclitaxel na benzyl analọgụ erughị 1.8.Chromatograph the Standard solution, wee dekọọ nzaghachi kacha elu dị ka akwadoro maka Usoro: ụkpụrụ agbakwunyere maka injections oyiri abụghị ihe karịrị 2.0%.[ndeba ama-Maka ebumnuche nke njirimara kachasị elu, a na-enye oge njigide oge dị nso na Tebụl 3. A na-atụ oge njide nke ikwu na Paclitaxel.]
Tebụl 3
Oke Oge Njido Aha (%)
Analọgụ Propyl1 0.54 0.2
Cephalomannine (ihe metụtara Paclitaxel A) 0.76 0.5
sec-Butyl analọg2 0.81 0.2
n-Butyl analọgụ3 0.89 0.1
Ihe analog nke Benzyl 1.10 0.4
Baccatin VI 1.23 0.2
Pentyl analog 1.31 0.2
7-Epipaclitaxel 1.51 0.4
1 A na-ekenye aha kemịkalụ na-esote Propyl analọgụ:Baccatin III 13-ester nwere (2R,3S) -3-butanoylamino-2-hydroxy-3-phenylpropanoic acid.
2 A na-ekenye aha kemịkalụ na-esote sec-Butyl analọgụ metụtara ya:Baccatin III 13-ester na (2R,3S) -2-hydroxy-3- (2-methylbutanoylamino) -3-phenylpropanoic acid.
3 A na-ekenye aha kemịkal na-esote n-Butyl analọgụ metụtara ya:Baccatin III 13-ester nwere (2S,3S) -2-hydroxy-3-(pentanoylamino) -3-phenylpropanoic acid.
4 A na-ekenye aha kemịkalụ a na njikọ Pentyl analọg:Baccatin III 13-ester nwere (2R,3S)-3-(hexanoylamino) -2-hydroxy-3-phenylpropanoic acid.
Usoro-Tinye otu olu (ihe dị ka 12 µL) nke ngwọta Nnwale n'ime chromatograph, dekọọ chromatogram, ma tụọ mpaghara maka ọnụ ọnụ niile.Gbakọọ pasent nke adịghị ọcha ọ bụla na mpaghara Paclitaxel nke usoro a were were:
100 (ri / rU)
nke ri bụ nzaghachi nke onye ọ bụla adịghị ọcha;na rU bụ nchikota nke mpaghara niile elu nke enwetara site na ngwọta ule.Na mgbakwunye na ịgafeghị oke maka adịghị ọcha metụtara paclitaxel na Tebụl 3, ọ bụghị karịa 0.1% nke adịghị ọcha ọ bụla ọzọ ka a hụrụ;na ọ bụghị ihe karịrị 2.0% nke mkpokọta adịghị achọta.
Nyocha -
Diluent- Kwadebe ngwakọta nke methanol na acetic acid (200: 1).
Usoro mkpanaaka - Kwadebe ngwakọta mmiri na acetonitrile akọrọ na nke gbazere (11:9).Mee mgbanwe ọ bụrụ na ọ dị mkpa (lee Dabara Sistemu n'okpuru Chromatography 621).
Standard nkwadebe-gbari, iji sonication ma ọ bụrụ na ọ dị mkpa, ihe ziri ezi tụrụ ibu nke USP Paclitaxel RS na diluent, na itughari quantitatively, na stepwise ma ọ bụrụ na ọ dị mkpa, na diluent nweta ngwọta na-enwe a maara ịta nke banyere 1 mg kwa ml.
Nkwadebe nyocha - Nyefee ihe dị ka 10 mg nke Paclitaxel, tụọ ya nke ọma, gaa na flask volumetric 10-mL.Gbanyụọ na diluent, na-eji sonication ma ọ bụrụ na ọ dị mkpa, gbanye ya na diluent ka ọ bụrụ olu, na mix.
Usoro Chromatographic (lee Chromatography <621>) -Kromatograph mmiri mmiri nwere ihe nchọta 227-nm yana kọlụm 4.6-mm × 25-cm nke nwere ngwugwu 5-µm L43.Onu ogugu a bu ihe dika 1.5 ml kwa nkeji.Chromatograph the Standard nkwadebe, na dekọọ nzaghachi kasị elu dị ka a na-eduzi maka Usoro: ihe ọdụdụ dị n'etiti 0.7 na 1.3;na ndị ikwu ọkọlọtọ ndiiche maka oyiri injections abụghị ihe karịrị 1.5%.
Usoro-iche iche nha nha nha (ihe dị ka 10 µL) nke nkwadebe ọkọlọtọ na nkwadebe Assay n'ime chromatograph, dekọọ chromatograms, wee tụọ mpaghara maka ọnụ ọgụgụ ndị bụ isi.Gbakọọ ọnụọgụ, na mg, nke C47H51NO14 n'ime akụkụ nke Paclitaxel nke usoro a bu:
10C (rU / rS)
nke C bụ ntinye uche, na mg kwa ml, nke USP Paclitaxel RS na nkwadebe Standard;na rU na rS bụ nzaghachi kachasị elu maka paclitaxel nwetara site na nkwadebe Assay na Standard nkwadebe, n'otu n'otu.

Uru:

Ike zuru oke: akụrụngwa na ndị ọrụ nka zuru oke

Ọrụ Ọkachamara: Otu nkwụsị ịzụrụ ọrụ

Ihe ngwugwu OEM: ngwugwu omenala na akara dị

Nnyefe ngwa ngwa: Ọ bụrụ n'ime ngwaahịa, ekwenyere nnyefe ụbọchị atọ

Nkwanye kwụsiri ike: Jikwaa ngwaahịa ezi uche dị na ya

Nkwado nka na ụzụ: Ngwọta teknụzụ dị

Ọrụ Synthesis Custom: sitere na gram ruo kilos

Ogo dị elu: guzobe usoro mmesi obi ike zuru oke

Ajụjụ:

Kedu ka esi azụta?Biko kpọtụrụDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com 

Ahụmịhe afọ 15?Anyị nwere ihe karịrị 15 afọ nke ahụmahụ na mmepụta na mbupụ nke a dịgasị iche iche nke elu mma pharmaceutical intermediates ma ọ bụ ezi kemịkal.

Isi ahịa?Na-ere ahịa ụlọ, North America, Europe, India, Korea, Japanese, Australia, wdg.

Uru?Ogo kachasị elu, ọnụ ahịa dị ọnụ ala, ọrụ ọkachamara na nkwado teknụzụ, nnyefe ngwa ngwa.

OgoNkwenye?Usoro njikwa mma siri ike.Ngwá ọrụ ọkachamara maka nyocha gụnyere NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, wdg.

Ihe atụ?Ọtụtụ ngwaahịa na-enye ihe nlele efu maka nyocha dị mma, ndị ahịa kwesịrị ịkwụ ụgwọ mbupu.

Nyocha ụlọ ọrụ?Nnabata nyocha ụlọ ọrụ.Biko mee oge oge tupu oge eruo.

MOQ?Enweghị MOQ.A na-anabata obere usoro.

Oge Mbuga ozi? Ọ bụrụ n'ime ngwaahịa, ekwenyere nnyefe ụbọchị atọ.

Ụgbọ njem?Site Express (FedEx, DHL), nke ikuku, site n'oké osimiri.

Akwụkwọ?Mgbe ọrụ ahịa gasịrị: COA, MOA, ROS, MSDS, wdg nwere ike ịnye.

Synthesis omenala?Nwere ike ịnye ọrụ nhazi ahaziri iche ka ọ dabara mkpa nyocha gị nke ọma.

Usoro ịkwụ ụgwọ?A ga-ebu ụzọ ziga akwụkwọ ọnụahịa Proforma mgbe nkwenye nke iwu, kpuchiri ozi ụlọ akụ anyị.Ịkwụ ụgwọ site na T/T (Telex Nyefee), PayPal, Western Union, wdg.

33069-62-4 - Ozi nchekwa:

Ihe akara egwu Xn - na-emerụ ahụ
Koodu ihe ize ndụ R37/38 - na-akpasu iwe na sistem iku ume na akpụkpọ ahụ.
R41 - ihe ize ndụ nke nnukwu mmebi anya
R42/43 - nwere ike ịkpata uche site na iku ume na kọntaktị anụ ahụ.
R62 - Ihe ize ndụ nke enweghị ike ịmụ nwa
R68 - Ihe ize ndụ nwere ike inwe mmetụta enweghị ike ịgbagha
R40 - Ihe akaebe nwere oke nke mmetụta carcinogenic
R48 - Ihe ize ndụ nke mmebi ahụike siri ike site na ikpughe ogologo oge
R20 / 21/22 - na-emerụ ahụ site na iku ume, na kọntaktị na akpụkpọ ahụ ma ọ bụrụ na loro ya.
R68/20/21/22 -
Nkọwa nchekwa S22 - Ekula uzuzu.
S26 - N'ihe banyere kọntaktị na anya, kpochaa ozugbo na ọtụtụ mmiri ma chọọ ndụmọdụ ahụike.
S36/37/39 - Yiri uwe nchebe kwesịrị ekwesị, uwe aka na nchebe anya / ihu.
S45 - Ọ bụrụ na ihe mberede ma ọ bụ ọ bụrụ na ahụ adịghị gị mma, chọọ ndụmọdụ ahụike ozugbo (gosi akara ahụ mgbe ọ bụla enwere ike.)
UN ID 1544
WGK Germany 3
RTECS DA8340700
FLUKA BRAND F CODES 10-21
Koodu HS 2932999021
Klas 6.1 (b) egwu
Otu ngwugwu III
Nsi LD50 intraperitoneal na òké: 128mg/kg

33069-62-4 - Nkọwa:

Paclitaxel (Taxol) (CAS: 33069-62-4), ngwaahịa sitere n'okike dịpụrụ adịpụ na ogbugbo nke Pacific yew, dị irè n'ịgwọ ọrịa cancer ovarian metastatic refractory.N'adịghị ka ndị ọrụ antineoplastic ọ bụla ọzọ, paclitaxel na-egosi na ọ nwere ọtụtụ usoro omume, gụnyere ihe antimicrotubule site na nkwalite tubulin polymerization na nkwụsi ike nke microtubules, si otú ahụ kwụsị mitosis na ịkwalite ọnwụ cell.Ọbịbịa nke paclitaxel na-ejedebe site na ụbara ihe okike ya dị ala ma ugbu a a na-arụpụta ya site na ụzọ semi-synthetic sitere na deacetylbaccatin Ⅲ nke dịpụrụ adịpụ na agịga nke osisi yew.Emechara n'oge na-adịbeghị anya ngụkọta ngụkọta nke taxol abụọ meriri n'usoro nhazi nke aha aha ahụ ma nwee ike ịba uru n'inweta ụfọdụ analogs nwere njikọ chiri anya, ụfọdụ n'ime ha achọpụtala na ha nwere ọrụ antitumor.Paclitaxel nwere ikike iji na-agwọ ọrịa cancer ara metastatic, kansa akpa ume, isi na olu kansa, na melanoma na-adịghị mma.

33069-62-4 - Akụkọ ihe mere eme:

E kewapụrụ ihe ndị na-egbu egbu dị na alaka na akwụkwọ Taxus chinensis na 1856 wee kpọọ aha "taxine," nke a chọpụtara dị ka ụdị alkaloid ọcha.Ka ọ dị ugbu a, n'etiti ọgwụ mgbochi niile, ire paclitaxel na-aghọ nke mbụ n'ụwa dịka ọgwụ mgbochi ọrịa cancer nke a ma ama nke nwere nnukwu ọrụ dị iche iche.N'October 1995, China ghọrọ mba nke abụọ na-emepụta paclitaxel na ntụtụ ya n'ụwa.Enwetara mmezu a n'okpuru mbọ na-adịghị agwụ agwụ nke ndị na-eme nchọpụta na Institute of Materia Medica, Ụlọ Akwụkwọ Academy of Medical Sciences nke China.

33069-62-4 - eji:

Paclitaxel (CAS: 33069-62-4) bụ antineoplastic nke a na-eji agwọ ndị ọrịa nwere ngụgụ, ovarian, cancer ara, isi na olu cancer, na ụdị advanc ed nke sarcoma Kaposi.Paclitaxel bụ ihe mgbochi mitotic ejiri na chemotherapy.A na-ejikwa ya na ọmụmụ ihe nhazi na ọrụ nke microtubles n'ime tubulin.
Paclitaxel nwere mmetụta dị mma na ọrịa cancer ovarian refractory na ọrịa ara ara na ọgwụ ndị na-eguzogide ọgwụ dị ka ọrịa cancer ovarian na platinum, na atụmanya dị mma maka ọgwụgwọ ọrịa cancer prostate, isi na olu, cancer esophageal, germ cell tumor, endometrial cancer, lymphoma, ọrịa kansa eriri afọ, ọrịa kansa tract digestive elu, obere cell na ọrịa kansa akpa ume na-abụghị obere cell.

33069-62-4 - Ngosipụta:

Paclitaxel (Taxol) (CAS: 33069-62-4) bụ ihe dị mgbagwoju anya nke ukwuu, nke dịpụrụ adịpụ site na ogbugbo nke osisi yew Pacific.Ọ na-ejikọta ya na tubulin dimers na microtubulin filaments, na-akwalite mgbakọ nke filaments na igbochi ha depolymerization.Mmụba a na nkwụsi ike nke microfilaments na-ebute nkwụsị nke mitosis na cytotoxicity ma na-akpaghasị ọrụ ndị ọzọ microtubular nkịtị, dị ka njem axonal na eriri irighiri akwara.Isi usoro nke nguzogide nke achọpụtara maka paclitaxel bụ ibupụ n'ime mkpụrụ ndụ tumo, nke na-eduga n'ịbelata mkpokọta ọgwụ intracellular.Ụdị nguzogide a bụ onye na-ebufe ọtụtụ ọgwụ P-glycoprotein.

33069-62-4 - Mmeghachi omume ikuku na mmiri:

Ọ nwere ike ịdị nro maka ikpughe mmiri ruo ogologo oge.

Dee ozi gị ebe a ziga anyị ya